Compare Cenovus Energy Inc (CVE) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Cenovus Energy Inc trades at $31.39 (market cap $57.90B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Cenovus Energy Inc is far larger — about 4.6× Halozyme Therapeutics Inc. Common Stock's market cap, and Cenovus Energy Inc pays a 1.97% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| CVE | HALO | |
|---|---|---|
Market Cap | $57.90B | $12.58B |
Volume | 7,863,588 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $33.92 | $115.22 |
52-Week Low | $15.85 | $61.63 |
Typical Hold Time | 46 Days | 1 Days |
Enterprise Value | $63.84B | $14.49B |
Dividend Yield | 1.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $31.49, up 2.81% today, with a bullish technical signal and strong fundamental metrics including a P/E of 12.43 and ROE of 20.96%. The company has beaten earnings estimates in three of the last four quarters and maintains solid cash flow generation despite recent net cash outflows. Recent analyst upgrades and positive media coverage highlight growing investor confidence in the energy sector.
CVE presents a compelling value opportunity with attractive valuation ratios and strong profitability metrics. Key risks include commodity price volatility and execution challenges in capital investments. Wall Street sentiment is cautiously optimistic with 40.7% buy ratings, though the majority maintain hold positions awaiting clearer earnings momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
